Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01034 (
cystatin C
)
3,397
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Surfactant proteins A and B (SP-A and SP-B) enter the circulation in a manner that acutely reflects changes in pulmonary function in patients with acute respiratory failure (ARF). There is a small but significant gradient in SP-A and SP-B from arterial to mixed venous (A-V) blood, and since we have detected both proteins in urine, the kidney may be a major site of their systemic clearance. Clara cell secretory protein 16 (CC16), which leaks from the respiratory tract, is known to be freely eliminated by the kidney. Lung plasma protein levels will depend on the rates of both protein entry into and clearance from plasma. In order to study the limiting variable determining these levels, we compared plasma CC16, SP-A, and SP-B in matching A-V blood samples from 37 ARF patients with indices of lung dysfunction and glomerular filtration rate (GFR) (of plasma
cystatin C
and
creatinine
). Cystatin C, CC16, SP-A, and SP-B were reduced in mixed venous plasma (all p < 0.001) and their A-V gradients were directly related to their arterial levels (all p < 0.03). Whereas CC16, SP-A, and SP-B reflected blood oxygenation (all p < 0.05), only SP-A and SP-B were related to lung injury score (LIS) (both p < 0.05). In contrast, whereas the clearances of both CC16 and
cystatin C
were related to that of
creatinine
(p < 0.02 for both), the clearances of SP-A and SP-B were not. Our study confirms that all three lung proteins are acutely cleared from the circulation of patients with ARF (half-lives < 18 min), and we conclude that whereas the plasma concentration of CC16 depends on GFR, plasma concentrations of SP-A and SP-B reflect lung function independently of this variable.
...
PMID:Clearance of Clara cell secretory protein 16 (CC16) and surfactant proteins A and B from blood in acute respiratory failure. 981 4
The literature does not contain reports regarding teicoplanin overdose in newborns. In a neonate with a history of recent postasphyctic acute renal failure which recovered within 7 days of life, antibiotic therapy with teicoplanin was started for sepsis due to Staphylococcus hominis. However, for 5 days the dosage was excessive (20 mg/kg twice daily instead of an initial dose of 16 mg/kg and then doses of 8 mg/kg once daily). Once this error had been noted, therapy was immediately suspended. Clinically the newborn had improved and blood culture at the end of the therapy was negative. Biohumoral tests revealed constantly normal levels of serum
creatinine
, serum
cystatin C
and blood nitrogen. Urinary parameters of tubulotoxicity were also within normal values. Urinary epidermal growth factor was increased. Teicoplanin was well tolerated at the renal level in the newborn even in this case of excessive dosage.
...
PMID:Renal tolerability of teicoplanin in a case of neonatal overdose. 982 56
Human
cystatin C
is a low molecular mass protein of 13359 Dalton recently proposed as a new very sensitive marker of changes in glomerular filtration rate. Serum
cystatin C
concentration correlates negatively with glomerular filtration rate as well as or better than
creatinine
. We evaluated a recently introduced automated nephelometric immunoassay for
cystatin C
in serum or EDTA-plasma samples on the Behring Nephelometer System. The assay consists of incubating the 100-fold diluted sample for 6 minutes with latex particles covalently coated with anti-human
cystatin C
antibodies, and then quantifying the change of light-scatter produced. Method reproducibility is satisfactory, the intra- and inter-assay coefficients of variation ranging from 1.58% to 3.77% and from 5.6% to 11.47% respectively. Rheumatoid factor (< or = 1116 IU/ml), bilirubin (< or = 418 micrommol/l), triglycerides (10.47 mmol/), and haemoglobin (12 g/l) do not significantly interfere in the assay. No significant difference was found in
cystatin C
concentration between serum and EDTA-plasma samples. Cystatin C is stable in serum samples stored under different conditions up to one month. This method correlates well (mean difference=-0.536+/-0.307 mg/l) with another commercially available particle-enhanced turbidimetric immunoassay. Cystatin C offers better clinical sensitivity than
creatinine
for discriminating patients with normal renal function and those with mild-to-moderate reduction in renal function. This method is suitable for routine
cystatin C
measurement, including emergencies.
...
PMID:Quantitative automated particle-enhanced immunonephelometric assay for the routinary measurement of human cystatin C. 987 92
Serum
creatinine
, a surrogate for both renal function and homocysteine generation, is an important determinant of fasting plasma total homocysteine levels in stable renal transplant recipients. In this study, it is hypothesized that among stable renal transplant recipients with normal
creatinine
levels (i.e., < or = 1.5 mg/dl), serum
cystatin C
, a more sensitive indicator of GFR, would better predict fasting total homocysteine levels compared with serum
creatinine
. Fasting plasma total homocysteine, folate, vitamin B12, and pyridoxal 5'-phosphate levels, along with serum
cystatin C
,
creatinine
, and albumin levels, were determined in 28 consecutive renal transplant recipients (mean age 47 +/- 14 yr; 60.7% men) with stable allograft function, whose serum
creatinine
was < or = 1.5 mg/dl. General linear modeling with analysis of covariance revealed that serum
cystatin C
was independently predictive (partial R = 0.494; P = 0.023) of fasting total homocysteine levels after adjustment for age, gender, vitamin status, albumin, and
creatinine
levels. In contrast,
creatinine
levels were not predictive of fasting total homocysteine levels in this model (P = 0.110) or an identical model that excluded
cystatin C
(P = 0.131). Serum
cystatin C
levels may reflect subtle decreases in renal function that independently predict fasting total homocysteine levels among stable renal transplant recipients with a normal serum
creatinine
.
...
PMID:Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine. 989 Mar 23
The protease inhibitor
cystatin C
is a non-glycosylated low molecular weight protein (Mr=13359) which is produced by all nucleated cells at a constant rate, freely filtered by the renal glomeruli, and catabolized in the tubuli. The aim of the study was to elucidate the applicability of serum
cystatin C
as a marker of glomerular filtration rate (GFR) in patients with various kidney diseases with a wide range of renal function and in dialysis patients. Seventy-six patients with various kidney diseases (aged 20 to 79 years) and 61 dialysis patients (aged 21 to 82 years) were included. Serum
cystatin C
was measured by automated particle-enhanced immunoturbidimetry, serum and urine
creatinine
by an enzymatic method, and GFR by 99mTc-DTPA-clearance using a single plasma sample method. Serum
cystatin C
in patients with various kidney diseases was 1.90+/-0.98 mg/L (mean+/-SD) and in dialysis patients 7.14+/-1.91 mg/L. In the non-dialysis patients a linear relationship was found between 99mTc-DTPA-clearance and 1/serum
cystatin C
(r=0.91, p-value<0.0001), 1/serum
creatinine
(r=0.89, p-value<0.0001), and
creatinine
-clearance (r=0.88, p-value<0.0001). Comparison of the non-parametric ROC plots for serum
cystatin C
(area under the curve (AUC)=0.9665; SE=0.0169), serum
creatinine
(AUC=0.9554; SE=0.0205), and
creatinine
-clearance (AUC=0.9731; SE=0.0160) revealed no significant differences (p-values: 0.50, 0.78, and 0.49). In conclusion,
cystatin C
may be a likewise good marker of the GFR as serum
creatinine
and
creatinine
-clearance,
cystatin C
having the advantage being independent of gender and muscle mass.
...
PMID:Serum cystatin C as a marker of the renal function. 989 Mar 42
Since 1985,
cystatin C
has been suggested to be a marker of the renal function. Cystatin C is a proteinase inhibitor with a low molecular weight (M(r) = 13359). It is produced at a constant rate in all nucleated cells investigated to date, freely filtered in the renal glomeruli and reabsorbed and catabolised in the proximal tubules. The concentration of serum
cystatin C
is mainly determined by glomerular filtration, which makes
cystatin C
an endogenous marker of glomerular filtration rate (GFR). There are few data describing the influence of various factors on the production and elimination of
cystatin C
. Fully automated assays using particle-enhanced turbidimetry or particle-enhanced nephelometry are available and the assays are precise, rapid and usable in clinical routine practice. Reference intervals have been determined for
cystatin C
in adults and in children older than one year. It has been suggested that the same reference interval can be used in children older than one year and in adults without gender differences, on the assumption that the same method with the same standardisation is used. Several studies including adults and children with different renal diseases with various kidney function have suggested serum
cystatin C
to be a better marker of GFR than serum
creatinine
.
...
PMID:Serum cystatin C as an endogenous marker of the renal function--a review. 1036 8
Recently, the reciprocal of
cystatin C
(Cys-C), a non-glycosylated 13-kilodalton protein that is produced by all investigated nucleated cells, was found to correlate closely with glomerular filtration rate (GFR). In order to determine the diagnostic validity in children for the detection of impaired GFR, venous blood samples from 381 children (aged 1.7-18 years) with various renal pathology referred for 51Cr-EDTA clearance investigations were obtained for measurement of Cys-C as well as beta2-microglobulin (beta2-MG) and serum
creatinine
. Two hundred and sixteen children with clearance values >90 ml/min per 1.73 m2 constituted a control group, with a normal GFR. In the control group, Cys-C values were normally distributed with a mean of 0.94+/-0.27 mg/l and an upper reference limit (97.5th percentile) of 1.47 mg/l. In all children, there was a positive correlation between 51Cr-EDTA clearance and the reciprocal of Cys-C (r=0.64, P<0.0001), beta2-MG (r=0.59, P<0.0001),
creatinine
(r=0.55, P<0.0001), and the height/
creatinine
ratio (r=0.73, P<0.0001). Receiver-operating characteristics analysis showed that there were no significant differences between these three parameters for discriminating between patients with normal and reduced GFR, although there was a tendency towards the best diagnostic sensitivity of the GFR estimate according to the Schwartz formula. We conclude that for the detection of mildly impaired GFR, a full clearance study cannot be replaced by measurement of serum Cys-C or beta2-MG concentrations.
...
PMID:Diagnostic sensitivity of serum cystatin for impaired glomerular filtration rate. 1045 78
Cystatin C is a non-glycated 13-kilodalton basic protein produced by all nucleated cells. The low molecular mass and the basic nature of
cystatin C
, in combination with its stable production rate, suggest that the glomerular filtration rate (GFR) is the major determinant of
cystatin C
concentration in the peripheral circulation. Recently published studies have shown that
cystatin C
correlates more strongly than
creatinine
with GFR measured using the 51Cr-EDTA clearance. The aim of this study was to evaluate serum
cystatin C
as a marker for GFR in children. GFR was determined on medical indications using the 51Cr-EDTA technique in pediatric patients (2-16 years) in our renal unit. Simultaneously their
cystatin C
and
creatinine
concentrations were also measured. Of our 52 patients, 19 had a reduced renal function (<GFR 89 ml/min per 1.73 m2) based on the 51Cr-EDTA clearance. The correlation of
cystatin C
with the isotopic measurement of GFR tended to be stronger (r=0.89, P=0.073) than that of
creatinine
(r=0.80). Receiver operating characteristic analysis showed that the diagnostic accuracy of
cystatin C
was better (P=0.037) than that of
creatinine
in discriminating between subjects with normal renal function and those with reduced GFR. This study demonstrates that serum
cystatin C
has an increased diagnostic accuracy for reduced GFR when compared with serum
creatinine
. Hence,
cystatin C
seems to be an attractive alternative for the estimation of GFR in children.
...
PMID:Cystatin C as a marker for glomerular filtration rate in pediatric patients. 1045 79
Both aprotinin and gentamicin-vancomycin antibiotic prophylaxis have been used widely in cardiac surgery to prevent bleeding and infections, respectively. As the drugs are excreted almost entirely by glomerular filtration, we investigated their action on renal function when administered either separately or together. To increase consistency, we measured serum concentrations of
creatinine
and
cystatin C
, a new marker of glomerular filtration rate, that many recent studies have shown to be more sensitive than serum
creatinine
. One hundred patients undergoing coronary artery bypass surgery were allocated randomly to one of four groups: group A received antibiotic prophylaxis with cefamandole and no aprotinin; group B received cefamandole and high-dose aprotinin; group C received antibiotic prophylaxis with gentamicin and vancomycin, but no aprotinin; and group D received both high-dose aprotinin and gentamicin-vancomycin antibiotic prophylaxis. Data from 84 patients, for whom data collection was complete, were analysed. In the first week after operation, mean serum concentrations of
cystatin C
and
creatinine
either remained constant or decreased slowly in all groups, except for group D. In group D, both markers increased gradually from postoperative day 2 onwards. The increase in
cystatin C
was significant on postoperative day 5 (from mean 1.02 (SD 0.11) mg litre-1 before operation to 1.35 (0.32) mg litre-1; P < 0.05), reaching a peak on postoperative day 7 (1.45 (0.35) mg litre-1; P < 0.05), while the increase in
creatinine
concentration was significant on postoperative day 6 (from 1.05 (0.16) mg dl-1 before operation to 1.29 (0.34) mg dl-1; P < 0.05). We conclude that simultaneous administration of high-dose aprotinin and prophylactic use of gentamicin with vancomycin increased serum concentrations of
cystatin C
and
creatinine
in the first postoperative week in patients undergoing cardiac surgery.
...
PMID:High-dose aprotinin with gentamicin-vancomycin antibiotic prophylaxis increases blood concentrations of creatinine and cystatin C in patients undergoing coronary artery bypass grafting. 1047 17
Serum
creatinine
, a surrogate for both renal function and homocysteine generation, is a determinant of fasting plasma total homocysteine levels in coronary artery disease (CAD) patients. We hypothesized that among stable-CAD patients with normal
creatinine
levels (ie, </=1.4 mg/dL), serum
cystatin C
, a more sensitive indicator of glomerular filtration rate, would better predict fasting total homocysteine levels in comparison with serum
creatinine
. Fasting plasma total homocysteine, folate, vitamin B(12), and pyridoxal 5'-phosphate levels, along with serum
cystatin C
,
creatinine
, and albumin levels, were determined in 164 consecutive stable-CAD patients (mean+/-SD age, 61+/-9 years; 78.7% men) whose serum
creatinine
level was </=1.4 mg/dL. All subjects were examined at least 3 to 4 months after the widespread availability of cereal grain flour products fortified with folic acid. General linear modeling with ANCOVA revealed that serum
cystatin C
(P<0.001), B(12) (P<0.001), age (P=0.002), albumin (P=0.008), and sex (P=0.024) were independent determinants of fasting total homocysteine levels. Cystatin C alone determined over half of the variability (ie, R(2)) in total homocysteine levels accounted for by these 5 independent regressors. In contrast,
creatinine
, folate, and pyridoxal 5'-phosphate were not independently predictive of fasting total homocysteine levels (P>0.2). Consistent with the impact of folic acid fortification of cereal grain flour in the general population, only 1 of the CAD subjects (0.6%) had a plasma folate level <3 ng/mL. We conclude that serum
cystatin C
levels may reflect subtle decreases in renal function that independently predict fasting total homocysteine levels among stable-CAD patients with normal serum
creatinine
.
...
PMID:Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine. 1047 68
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>